Larvol Delta - Efficacy-and-safety-of-abdakibart-a-selective-antiIL1-agent-for-treatment-of-moderate-to-severe-hidradenitis-suppurativa-primary-results-of-the-placebocontrolled-Phase-2-LOTUS-Trial

abdakibart (AVTX-009) - Avalo Therap

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/64392

Martina L. Porter

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next